Innovative Eyewear, Inc. (LUCY)
USD 1.79
(-3.76%)
USD 1.79
(-3.76%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.66 Million USD | -17.28% |
| 2022 | -5.68 Million USD | -75.12% |
| 2021 | -3.24 Million USD | -322.36% |
| 2020 | -768.18 Thousand USD | -192.5% |
| 2019 | -262.62 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.94 Million USD | 1.16% |
| 2024 Q1 | -1.97 Million USD | 17.65% |
| 2023 Q4 | -2.39 Million USD | -54.32% |
| 2023 FY | -6.66 Million USD | -17.28% |
| 2023 Q3 | -1.55 Million USD | -20.45% |
| 2023 Q2 | -1.28 Million USD | 9.99% |
| 2023 Q1 | -1.43 Million USD | 23.78% |
| 2022 Q2 | -1.19 Million USD | 1.06% |
| 2022 Q1 | -1.2 Million USD | 12.91% |
| 2022 FY | -5.68 Million USD | -75.12% |
| 2022 Q4 | -1.87 Million USD | -33.67% |
| 2022 Q3 | -1.4 Million USD | -17.63% |
| 2021 Q1 | -221.71 Thousand USD | -4.55% |
| 2021 FY | -3.24 Million USD | -322.36% |
| 2021 Q2 | -536.6 Thousand USD | -142.02% |
| 2021 Q4 | -1.38 Million USD | -25.86% |
| 2021 Q3 | -1.1 Million USD | -105.14% |
| 2020 Q2 | -192.79 Thousand USD | 0.0% |
| 2020 FY | -768.18 Thousand USD | -192.5% |
| 2020 Q4 | -212.06 Thousand USD | -24.37% |
| 2020 Q3 | -170.52 Thousand USD | 11.55% |
| 2020 Q1 | -192.79 Thousand USD | 0.0% |
| 2019 FY | -262.62 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 89.477% |
| AngioDynamics, Inc. | -184.34 Million USD | 96.385% |
| AtriCure, Inc. | -30.43 Million USD | 78.108% |
| Avinger, Inc. | -18.32 Million USD | 63.628% |
| Azenta, Inc. | -14.25 Million USD | 53.262% |
| BioLife Solutions, Inc. | -66.42 Million USD | 89.969% |
| The Cooper Companies, Inc. | 294.2 Million USD | 102.265% |
| Daxor Corporation | 280.64 Thousand USD | 2474.369% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 56.156% |
| Femasys Inc. | -14.24 Million USD | 53.23% |
| GlucoTrack, Inc. | -7.09 Million USD | 6.109% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -95.122% |
| Hologic, Inc. | 789.5 Million USD | 100.844% |
| ICU Medical, Inc. | -29.65 Million USD | 77.53% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.371% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 51.507% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 122.134% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -0.0% |
| Masimo Corporation | 81.5 Million USD | 108.176% |
| Microbot Medical Inc. | -10.74 Million USD | 37.957% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 157.318% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 107.058% |
| Nephros, Inc. | -1.57 Million USD | -323.075% |
| NovoCure Limited | -207.04 Million USD | 96.782% |
| NEXGEL, Inc. | -3.15 Million USD | -111.068% |
| NEXGEL, Inc. | -3.15 Million USD | -111.068% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 92.973% |
| OraSure Technologies, Inc. | 53.65 Million USD | 112.419% |
| Pro-Dex, Inc. | 2.12 Million USD | 413.278% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 84.214% |
| Predictive Oncology Inc. | -13.98 Million USD | 52.35% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -125.774% |
| QuidelOrtho Corporation | -10.1 Million USD | 34.025% |
| Repligen Corporation | 41.57 Million USD | 116.027% |
| Sanara MedTech Inc. | -4.3 Million USD | -54.848% |
| STAAR Surgical Company | 21.34 Million USD | 131.215% |
| Sharps Technology, Inc. | -9.84 Million USD | 32.294% |
| Utah Medical Products, Inc. | 16.63 Million USD | 140.057% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 94.952% |
| Jin Medical International Ltd. | 2.87 Million USD | 331.511% |